Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Karlan

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Cancer|November 29, 2024
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutationBryson W Katona, Jan Lubinski, Tuya Pal, et al.
BMC Cancer|November 11, 2025
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control studyMarta Seca, Jacek Gronwald, Tomasz Huzarski, et al.
Gynecologic Oncology|August 22, 2024
Incidence of endometrial cancer in BRCA mutation carriersJoanne Kotsopoulos, Jan Lubinski, Tomasz Huzarski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2012
Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2014
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutationAmy P M Finch, Jan Lubinski, Pål Møller, et al.
JAMA|July 13, 2006
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 MutationAmy Finch, Mario Beiner, Jan Lubinski, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Breast Cancer Research : BCR|March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriersEitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Cancer|November 29, 2024
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutationBryson W Katona, Jan Lubinski, Tuya Pal, et al.
BMC Cancer|November 11, 2025
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control studyMarta Seca, Jacek Gronwald, Tomasz Huzarski, et al.
Gynecologic Oncology|August 22, 2024
Incidence of endometrial cancer in BRCA mutation carriersJoanne Kotsopoulos, Jan Lubinski, Tomasz Huzarski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2012
Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2014
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutationAmy P M Finch, Jan Lubinski, Pål Møller, et al.
JAMA|July 13, 2006
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 MutationAmy Finch, Mario Beiner, Jan Lubinski, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Breast Cancer Research : BCR|March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriersEitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.
Pageof 9